Mineralys Therapeutics Inc (NAS:MLYS)
$ 30.4 -0.050 (-0.16%) Market Cap: 2.68 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 37/100